NCT05616338View on ClinicalTrials.gov

Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions
Severe AsthmaAllergic Bronchopulmonary Aspergillosis (ABPA)
Interventions
OTHER

Blood sample

"A blood sample and a nasal brush for each participant. The nasal brushing will allow the isolation of epithelial cells that will serve as a comparison for the bronchial tissue produced from blood-derived iPS.~A blood sample of approximately 14 ml will be taken for isolation and freezing of the blood mononuclear cells allowing the generation of iPS."

Trial Locations (1)

34295

university Hospital of Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER